» Articles » PMID: 18655850

Role of MicroRNAs in Diabetes

Overview
Specialties Biochemistry
Biophysics
Date 2008 Jul 29
PMID 18655850
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes is one of the most common chronic diseases in the world. Multiple and complex factors including various genetic and physiological changes can lead to type 1 and type 2 diabetes. However, the major mechanisms underlying the pathogenesis of diabetes remain obscure. With the recent discovery of microRNAs (miRNAs), these small ribonucleotides have been implicated as new players in the pathogenesis of diabetes and diabetes-associated complications. MiRNAs have been shown to regulate insulin production, insulin secretion, and insulin action. This review summarizes the recent progress in the cutting-edge research of miRNAs involved in diabetes and diabetes related complications.

Citing Articles

The MiR-139-5p and CXCR4 axis may play a role in high glucose-induced inflammation by regulating monocyte migration.

Li W, Xu G, Chai G, Ball A, Zhang Q, Kutryk M Sci Rep. 2025; 15(1):6738.

PMID: 40000897 PMC: 11861593. DOI: 10.1038/s41598-025-91100-1.


Emerging Roles of ncRNAs in Type 2 Diabetes Mellitus: From Mechanisms to Drug Discovery.

Yang Y, Cheng H Biomolecules. 2024; 14(11).

PMID: 39595541 PMC: 11592034. DOI: 10.3390/biom14111364.


Role of microRNAs in Diabetes-Associated Periodontitis: A Scoping Review.

Agnihotri R, Gaur S, Bhat S J Int Soc Prev Community Dent. 2024; 14(3):180-191.

PMID: 39055291 PMC: 11268527. DOI: 10.4103/jispcd.jispcd_3_24.


The role of miR-143/miR-145 in the development, diagnosis, and treatment of diabetes.

Rasmi Y, Mohamed Y, Alipour S, Ahmed S, Abdelmajed S J Diabetes Metab Disord. 2024; 23(1):39-47.

PMID: 38932869 PMC: 11196424. DOI: 10.1007/s40200-023-01317-y.


Altered expression of miR-375 and miR-541 in type 2 diabetes patients with and without coronary artery disease (CAD): the potential of miR-375 as a CAD biomarker.

Sangali P, Abdullahi S, Nosrati M, Khosravi-Asrami O, Mahrooz A, Bagheri A J Diabetes Metab Disord. 2024; 23(1):1101-1106.

PMID: 38932834 PMC: 11196532. DOI: 10.1007/s40200-024-01391-w.


References
1.
Lynn F, Skewes-Cox P, Kosaka Y, McManus M, Harfe B, German M . MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes. 2007; 56(12):2938-45. DOI: 10.2337/db07-0175. View

2.
Niu Z, Li A, Zhang S, Schwartz R . Serum response factor micromanaging cardiogenesis. Curr Opin Cell Biol. 2007; 19(6):618-27. PMC: 2735128. DOI: 10.1016/j.ceb.2007.09.013. View

3.
Cohen A, Horton E . Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve glycemic control. Curr Med Res Opin. 2007; 23(4):905-17. DOI: 10.1185/030079907x182068. View

4.
Smallridge R . A small fortune. Nat Rev Mol Cell Biol. 2001; 2(12):867. DOI: 10.1038/35103036. View

5.
Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi J . MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A. 2007; 104(9):3432-7. PMC: 1805579. DOI: 10.1073/pnas.0611192104. View